High Net Worth Advisory Group LLC Allakos Inc. Transaction History

High Net Worth Advisory Group LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 10, 2022	SELL	$2.6 - $6.14 $1,300 - $3,070	-500 Closed	0 $0
Q4 2021 Apr 27, 2022	BUY	$8.55 - $111.89 $4,275 - $55,945	500 New	500 $4,000

64.7M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $89.8M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of High Net Worth Advisory Group LLC, based on Form 13F filings with the SEC.

Stay updated on High Net Worth Advisory Group LLC with notifications on news.